ライフサイエンスコーパス: critically ill patient

1 myocardial injury from the infection (22% of critically ill patients).

2 chnical airway skills involved in managing a critically ill patient.

3 basic knowledge of physicians caring for the critically ill patient.

4 gs attention to the respiratory drive of the critically ill patient.

5 with hypoxia and hemodynamic instability in critically ill patients.

6 e respiratory distress syndrome is common in critically ill patients.

7 ologic outcome compared with normothermia in critically ill patients.

8 oalveolar lavage and cerebrospinal fluids of critically ill patients.

9 ting reversibility of acute kidney injury in critically ill patients.

10 the reversibility of acute kidney injury in critically ill patients.

11 own about their impact on the outcome of non-critically ill patients.

12 nt is not associated with a worse outcome in critically ill patients.

13 was associated with increase risk of harm in critically ill patients.

14 ement of impaired intestinal transit even in critically ill patients.

15 rt toward improving the delivery of care for critically ill patients.

16 Tracheal intubation is commonly performed in critically ill patients.

17 general population and defined subgroups of critically ill patients.

18 nfluencing delivery of early mobilization to critically ill patients.

19 intensive care-applied therapies applied to critically ill patients.

20 clock genes in healthy controls, but none in critically ill patients.

21 gnized clinical problem, typically occurs in critically ill patients.

22 ionale: Acidemia is a severe condition among critically ill patients.

23 es of hyperferritinemia in a mixed cohort of critically ill patients.

24 s with modern emergency airway management in critically ill patients.

25 Consecutive endotracheal intubations in critically ill patients.

26 aining who may be suddenly asked to care for critically ill patients.

27 ment of acquired liver injury and failure in critically ill patients.

28 help expand the donor pool in this subset of critically ill patients.

29 nation method for endotracheal intubation in critically ill patients.

30 ill continue to enhance our ability to treat critically ill patients.

31 xamination findings with 90-day mortality in critically ill patients.

32 gnostic yield of transvenous renal biopsy of critically ill patients.

33 may positively impact the care of high risk, critically ill patients.

34 restricting the ability to effectively treat critically ill patients.

35 ality was 5%, but significantly higher among critically ill patients.

36 n that has consistently reduced mortality in critically ill patients.

37 ctability in extubation failure detection in critically ill patients.

38 i responsible for blood stream infections in critically ill patients.

39 amples from a cohort of septic and nonseptic critically ill patients.

40 nce = end-systolic pressure/stroke volume in critically ill patients.

41 s and may help to prevent volume overload in critically ill patients.

42 contributor to morbidity and mortality among critically ill patients.

43 of iohexol clearance measurement in unstable critically ill patients.

44 gorithm to improve the overall care of dying critically ill patients.

45 ve alcohol consumption on kidney function in critically ill patients.

46 clinical judgment of the risk of seizures in critically ill patients.

47 racy of a blood glucose monitoring system in critically ill patients.

48 ability are associated with poor outcomes in critically ill patients.

49 in modifies duration of delirium and coma in critically ill patients.

50 n MRI at the point of care, particularly for critically ill patients.

51 e, blood pressure, and heart rate in febrile critically ill patients.

52 ains a major cause of respiratory failure in critically ill patients.

53 s and leading to questions over their use in critically ill patients.

54 ily risk of individual organ dysfunctions in critically ill patients.

55 tributor to weaning difficulty in ventilated critically ill patients.

56 atients was observed in this large cohort of critically ill patients.

57 s commonly used to assess immune function in critically ill patients.

58 ed with increased morbidity and mortality in critically ill patients.

59 of AKI, death, and other adverse outcomes in critically ill patients.

60 and contractile weakness of the diaphragm in critically ill patients.

61 lly in hospitalized and immunocompromised or critically ill patients.

62 amage in mechanically ventilated and sedated critically ill patients.

63 should be not used to track contractility in critically ill patients.

64 nary artery occlusion pressure in ventilated critically ill patients.

65 quently required for mechanically ventilated critically ill patients.

66 e of admission to the intensive care unit in critically ill patients.

67 and safe assessing thromboembolic disease in critically ill patients.

68 ten results in significant fluid overload in critically ill patients.

69 ate that is both common and consequential in critically ill patients.

70 e measure of the central circadian rhythm in critically ill patients.

71 N ratio correlated with improved outcome for critically ill patients.

72 gut-associated bacteria) predict outcomes in critically ill patients.

73 of epinephrine administration on outcome of critically ill patients.

74 Hyperferritinemia is frequently seen in critically ill patients.

75 tensive care unit, with a proven benefit for critically ill patients.

76 med for prolonged endotracheal intubation in critically ill patients.

77 the pathophysiology of respiratory drive in critically ill patients.

78 s, our institution prepared for an influx of critically ill patients.

79 ardiography as a predictor of outcomes among critically ill patients.

80 ility, organ injury and improved outcomes in critically ill patients.

81 organ support and of short-term mortality in critically ill patients.

82 smission and subsequent ESBL-E infections in critically-ill patients.

83 Very few articles pertained to transport of critically ill patients (4%).

84 Critically ill patients 6 months to 5 years old.

85 ependently predicts in-hospital mortality in critically ill patients across the glycemic spectrum.

86 conducted a prospective cohort study of 350 critically ill patients admitted to intensive care units

87 nd platelet activation in critically and non-critically ill patients admitted to the hospital with CO

88 In medical critically ill patients, although no randomized controll

89 We considered any outcome related to the critically ill patient and/or their family member, outco

90 ied in serum from 321 prospectively enrolled critically ill patients and compared with clinical outco

91 ghlighted other important considerations for critically ill patients and evaluated interventions to r

92 evidence on fluid overload and mortality in critically ill patients and have performed a meta-analys

93 Delayed gastric emptying occurs in critically ill patients and impairs the delivery, digest

94 lternative complement pathway in a series of critically ill patients and in a mouse pneumonia model.M

95 Focus on critically ill patients and included evaluations in othe

96 is a common cause of respiratory failure in critically ill patients and is defined by the acute onse

97 the dominant acute kidney injury etiology in critically ill patients and is often associated with a n

98 Stress hyperglycemia occurs in critically ill patients and may be a risk factor for sub

99 of any intervention or monitoring system in critically ill patients and reported mortality as a prim

100 for development of axonal polyneuropathy in critically ill patients and since insulin therapy may be

101 d that granular and autonomous monitoring of critically ill patients and their environment is feasibl

102 ve consensus and improve decision-making for critically ill patients and their family members at the

103 ze acute alterations of circadian rhythms in critically ill patients and to evaluate associations bet

104 e multicentral database of perioperative and critically ill patients and to use this automatic algori

105 Usual care (critically ill patients) and modified constant routine (

106 ean Outcome Registry in ICUs) enrolled 2,087 critically ill patients, and AdrenOSS-1 (Adrenomedullin

107 ll patients, very specific subpopulations of critically ill patients, and on early goal-directed ther

108 Cancer affects up to 20% of critically ill patients, and sepsis is one of the leadin

109 ctives: To determine if clinical outcomes of critically ill patients are predicted by features of the

110 e improvement for treatment of infections in critically ill patients, are lacking.

111 Surgical and critically ill patients at a tertiary medical center bet

112 equations against indirect calorimetry among critically ill patients at different phases of critical

113 In critically ill patients awaiting transfer from the emerg

114 strategies that improve clinical outcomes of critically ill patients boarded in the emergency departm

115 entral venous catheters, are often needed in critically ill patients, but also are associated with co

116 s are preparing for the anticipated surge in critically ill patients, but few are wholly equipped to

117 Frailty has prognostic importance among critically ill patients, but its impact on outcomes and

118 n was effective in enhancing the recovery of critically ill patients, but more large-scale, multicent

119 lues, the features more commonly observed in critically ill patients.(C) RSNA, 2020.

120 due to sepsis remains a persistent threat to critically ill patients confined to the intensive care u

121 lasma concentration-time data from 214 adult critically-ill patients (creatinine clearance 0-236mL/mi

122 More notably, critically ill patients displayed hallmarks of extrafoll

123 Diaphragm muscle fibers from critically ill patients displayed significant atrophy an

124 Rehabilitation interventions in critically ill patients do not influence mortality and a

125 gly considered as a bedside gold standard in critically ill patients due to its overwhelming advantag

126 de YY and ghrelin in control subjects and in critically ill patients, during feeding and fasting, and

127 In critically ill patients, effective arterial elastance ma

128 d a high diagnostic yield for these selected critically ill patients, even in the presence of multipl

129 thy should be managed as it would be for any critically ill patient, following the established practi

130 Critically ill patients for whom the physician decided t

131 one of the leading causes of mortality among critically ill patients globally.

132 Newly admitted critically ill patients, greater than or equal to 48 hou

133 We enrolled critically ill patients (>/=18 years) needing mechanical

134 Recent research in critically ill patients has highlighted other important

135 powerful diagnostic and prognostic marker in critically ill patients has recently accumulated.

136 ute lung injury (ALI), a common condition in critically ill patients, has limited treatments and high

137 Critically ill patients have manifest diaphragm muscle f

138 Chronically critically ill patients have recurrent infections, organ

139 (CKRT) can be a lifesaving intervention for critically ill patients; however, mortality remains high

140 Some critically ill patients in a medical intensive care unit

141 oninferiority trial designs and exclusion of critically ill patients in many trials.

142 pportunistic pathogen that primarily infects critically ill patients in nosocomial settings.

143 rowding and limited critical care resources, critically ill patients in the emergency department may

144 sts its possible role in the routine care of critically ill patients in the future.

145 P tool may be used in the future to stratify critically ill patients in the ICU according to their im

146 Uses of ketamine discussed focused on critically ill patients in the ICU and emergency departm

147 Among critically ill patients in the ICU, a nurse-led preventi

148 remains in identifying the immune profile of critically ill patients in the intensive care unit (ICU)

149 clearance are known predictors of outcome in critically ill patients in the intensive care unit (ICU)

150 Although one third or more of critically ill patients in the United States are obese,

151 ture of COVID-19 and the large population of critically ill patients included in these analyses, the

152 benefit in several disease states impacting critically ill patients including pain, alcohol withdraw

153 We studied 15 critically ill patients, including 10 with sepsis and fi

154 We studied 112 critically ill patients, including 53 with sepsis and 59

155 We studied 112 critically ill patients, including 53 with sepsis and 59

156 to address emergency department boarding of critically ill patients, including emergency department-

157 among patients with ESKD compared with other critically ill patients, including those with diseases o

158 ith early occurrence of new organ failure in critically ill patients, independently of respiratory st

159 In critically ill patients, infusing glucose with insulin d

160 Emergency department-based boarding of the critically ill patient is common, but no nationally repr

161 apted pathobiota." Under this framework, the critically ill patient is viewed as a host colonized by

162 t that chronic and current alcohol misuse in critically ill patients is associated with kidney dysfun

163 aims at showing that anxiety at admission in critically ill patients is associated with new organ fai

164 Delirium in critically ill patients is associated with poor clinical

165 ntinuous electroencephalography (EEG) use in critically ill patients is expanding.

166 The incidence of acute kidney injury in critically ill patients is increasing steeply.

167 onale: Recent studies have revealed that, in critically ill patients, lung microbiota are altered and

168 al distress in family members of chronically critically ill patients may need to target ICU nurses fo

169 rving hospitals using an inception cohort of critically ill patients.Measurements and Main Results: U

170 Among 217 critically ill patients, mortality for those who require

171 h combined antibiotic and steroid therapy in critically ill patients not fitting into established dis

172 o supraphysiologic Pa(O(2)) (hyperoxemia) in critically ill patients.Objectives: To examine the assoc

173 ecision-making by surrogates for chronically critically ill patients on mechanical ventilation.

174 In peripheral blood of critically ill patients, Orai1+ cells were significantly

175 m 53% in mild-to-moderate patients to 88% in critically ill patients (p=0.036).

176 ncentives for physicians to provide care for critically ill patients, particularly at institutions wi

177 enous extracorporeal membrane oxygenation in critically ill patients, particularly regarding safety a

178 alyzed data from a prospective cohort of 996 critically ill patients presenting with acute trauma and

179 Critically ill patients rapidly enter a state of behavio

180 the prevalence of venous thromboembolism in critically ill patients receiving different regimens of

181 nctive intermittent pneumatic compression in critically ill patients receiving pharmacologic thrombop

182 s of a hospital, and all hospitals will have critically ill patients regardless of designating a spec

183 amin C administration on clinical outcome in critically ill patients remain controversial.

184 Its incidence and outcome in critically ill patients remain, however, largely unknown

185 y and predicting in-hospital mortality among critically ill patients require time-consuming, error-pr

186 overload and major adverse kidney events in critically ill patients requiring continuous renal repla

187 sed as an inotropic and vasopressor agent in critically ill patients requiring hemodynamic support.

188 and will advance the study and management of critically ill patients requiring mechanical ventilation

189 To observe how surrogates of chronically critically ill patients respond to information about pro

190 ibe the determinants of respiratory drive in critically ill patients, review the tools available to a

191 phalopathy severity by Glasgow Coma Scale in critically ill patients (rho, -0.54; p = 0.036).

192 Critically ill patients routinely receive vancomycin as

193 e the performance of blood glucose meters in critically ill patient settings.

194 ere form of antibiotic-associated colitis in critically ill patients signified by microbiota depletio

195 Almost 10% of these critically ill patients subsequently die.

196 specially compared with other populations of critically ill patients such as sepsis or severe communi

197 Accurate diagnosis for Arabic speaking critically ill patients suffering from delirium is limit

198 100% occurrence of venous thromboembolism in critically ill patients supported by venovenous extracor

199 or of TimeSignature was higher in individual critically ill patients than healthy patients (4.90 vs 1

200 pecific clinical characteristics of infected critically ill patients that mediate the associated path

201 Among critically ill patients, the benefits of nutrition suppo

202 for continuous kidney replacement therapy in critically ill patients, the evidence for this recommend

203 The diverse responses of critically ill patients to infection with multi-drug res

204 ranging from the morbidity and mortality of critically ill patients to the diagnosis and prognosis o

205 de evidence that rapid admission of the most critically ill patients to the ICU might reduce hospital

206 egy on organ injury are less well studied in critically ill patients treated with continuous kidney r

207 e analysis of circulating cytokine levels in critically ill patients treated with mesenchymal stem/st

208 In critically ill patients, treatment dose or intensity is

209 eding versus Target Enteral Feeding in Adult Critically Ill Patients) trial.

210 atient-ventilator asynchrony is common among critically ill patients undergoing mechanical ventilatio

211 e accuracy in predicting 6-month outcomes of critically ill patients varied depending on the outcome

212 Engaging and empowering families of critically ill patients warrant further study.

213 Emergency department boarding of critically ill patients was common and was associated wi

214 Mortality among these critically ill patients was high.

215 In critically ill patients, we showed that mitophagy was in

216 Consecutive medical and surgical critically ill patients were enrolled between April 1, 2

217 In this prospective study, critically ill patients were enrolled immediately after

218 t least 24 hours and conventional therapy in critically ill patients were included.

219 n.Measurements and Main Results: Lungs of 91 critically ill patients were sampled using miniature BAL

220 n prominent IFN signatures were only seen in critically ill patients who also exhibited augmented inf

221 systemic inflammatory markers compared with critically ill patients who do not develop ICU-acquired

222 Participants were critically ill patients who regained mental capacity fol

223 Among critically ill patients who were receiving pharmacologic

224 A critically ill patient with multiple postoperative infec

225 The optimal management of the critically ill patient with sepsis and cirrhosis has not

226 strategies for renal replacement therapy in critically ill patients with acute kidney injury conduct

227 alysate temperature on hemodynamic status of critically ill patients with acute kidney injury during

228 Among critically ill patients with acute kidney injury receivi

229 In critically ill patients with acute kidney injury requiri

230 5 volatile organic compounds were greater in critically ill patients with acute kidney injury than in

231 Among critically ill patients with acute kidney injury, exposu

232 t practices in renal replacement therapy for critically ill patients with acute kidney injury.

233 Research evaluating outcomes in critically ill patients with acute respiratory and cardi

234 a potential infective complication affecting critically ill patients with acute respiratory distress

235 Whether earlier initiation of RRT in critically ill patients with AKI can improve outcomes re

236 Participants included critically ill patients with AKI requiring RRT who were

237 h independently associated with mortality in critically ill patients with AKI requiring RRT.

238 en established for administration of MSCs in critically ill patients with ARDS.

239 r a high CO2 gap predicts mortality in adult critically ill patients with circulatory shock.

240 tic value of lactate levels and clearance in critically ill patients with cirrhosis.

241 Ogilvie syndrome, mesenteric ischemia) among critically ill patients with coronavirus disease 2019 (C

242 mor necrosis factor alpha, IL-6, and IL-8 in critically ill patients with coronavirus disease 2019 (C

243 A large proportion of critically ill patients with coronavirus disease 2019 ha

244 organ failure, and could improve survival in critically ill patients with coronavirus disease 2019 in

245 We reviewed thromboelastography studies in critically ill patients with coronavirus disease 2019 to

246 In this cohort of critically ill patients with coronavirus disease 2019, n

247 Deep venous thrombosis is very common in critically ill patients with coronavirus disease 2019.

248 rohemorrhages were brain imaging features in critically ill patients with coronavirus disease 2019.

249 he cytokine milieu in the lungs and blood of critically ill patients with COVID-19 acute respiratory

250 In this study of critically ill patients with COVID-19 and acute respirat

251 AKI-RRT is common among critically ill patients with COVID-19 and is associated

252 Care) genome-wide association study in 2,244 critically ill patients with COVID-19 from 208 UK intens

253 idemiology, clinical course, and outcomes of critically ill patients with COVID-19 in this setting ar

254 nsive care unit (ICU) stay suggest that many critically ill patients with COVID-19 will face long-las

255 authors report brain imaging features in 11 critically ill patients with COVID-19 with persistently

256 irement were similar between SOT and non-SOT critically ill patients with COVID-19.

257 nthetic glucocorticoid, enhanced survival of critically ill patients with COVID-19.

258 Critically ill patients with deranged conventional coagu

259 arries a high risk of complications; half of critically ill patients with difficult airways experienc

260 atients with diseases of other major organs, critically ill patients with ESKD were not more likely t

261 retrospective, observational study included critically ill patients with influenza associated with p

262 pared to late treatment in a large cohort of critically ill patients with influenza of all types.

263 d easily available technique for identifying critically ill patients with intracranial hypertension.

264 In this case series of critically ill patients with laboratory-confirmed COVID-

265 This is a retrospective cohort study of critically ill patients with laboratory-confirmed MERS f

266 ntly associated with short-term mortality in critically ill patients with liver cirrhosis.

267 rferon (RBV/rIFN) therapy on the outcomes of critically ill patients with Middle East respiratory syn

268 Data from critically ill patients with neutropenic enterocolitis a

269 to confirm merits of nebulized amikacin for critically ill patients with nosocomial pneumonia.

270 the most challenging problems in the care of critically ill patients with oliguric acute kidney injur

271 Critically ill patients with requirement of continuous r

272 mendations for the use of corticosteroids in critically ill patients with sepsis and septic shock, ac

273 Critically ill patients with sepsis or septic shock are

274 presentation, outcome, and host response in critically ill patients with sepsis.

275 tcomes of atrial fibrillation in a cohort of critically ill patients with sepsis.

276 nt of acute respiratory distress syndrome in critically ill patients with sepsis.

277 thms to decrease duration of antibiotics for critically ill patients with sepsis.

278 o bring precision medicine to the bedside of critically ill patients with sepsis.

279 sal and potentially biomarker information in critically ill patients with sepsis.

280 m the Adjunctive Corticosteroid Treatment in Critically Ill Patients with Septic Shock and Activated

281 m the Adjunctive Corticosteroid Treatment in Critically Ill Patients with Septic Shock and Activated

282 d for Adjunctive Corticosteroid Treatment in Critically Ill Patients with Septic Shock and hydrocorti

283 ,658 (Adjunctive Corticosteroid Treatment in Critically Ill Patients with Septic Shock) and $30,911 (

284 Per Adjunctive Corticosteroid Treatment in Critically Ill Patients with Septic Shock, adjunctive hy

285 PATIENTS/Twenty-six critically ill patients with Sequential Organ Failure As

286 Thrombocytopenia is common in critically ill patients with severe acute kidney injury

287 The trial was terminated early after 596 critically ill patients with severe acute kidney injury

288 viral replication patterns, and outcomes of critically ill patients with severe acute respiratory in

289 hypotension during vasopressor support among critically ill patients with shock and to determine whet

290 on and adverse kidney-related outcomes among critically ill patients with shock.Objectives: To invest

291 trophilia can exclude bacterial pneumonia in critically ill patients with suspected infection and to

292 predictive value for bacterial pneumonia in critically ill patients with suspected infection.

293 Clinical Frailty Scale >= 5) and outcomes of critically ill patients with suspected infection.

294 ssue biomarkers for prognostic evaluation in critically ill patients with traumatic brain injury.

295 wever, the evidence base guiding the care of critically ill patients with tuberculous meningitis is p

296 gest that we should limit the PaO2 levels of critically ill patients within a safe range, as we do wi

297 r positive end-expiratory pressure (PEEP) in critically ill patients without acute respiratory distre

298 Compared with critically ill patients without major organ disease, pat

299 compared with placebo or no intervention in critically ill patients without neutropenia, but the qua

300 It allows prolonged hemodialysis sessions in critically ill patients without the need to systemically